NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-035-2010-0-US-01 INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS US 60/606,982 Abandoned
NCI E-234-2003-1-AU-03 Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas AU National Stage 2004271192 Expired
NCI E-108-2004-0-US-01 METHODS FOR DIAGNOSING LYMPHOMA TYPES US ORD 10/934,930 7711492 Issued PDF
NCI E-234-2003-1-PCT-01 Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas PCT PCT COMB PCT/US2004/029041 Expired
NCI E-234-2003-1-EP-06 Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas EP DIV 09170243.1 Abandoned
NCI E-234-2003-1-EP-05 Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas EP National Stage 04783330.6 Abandoned
NHLBI E-276-2004-0-US-01 Methods for Diagnosis of Atherosclerosis US 60/607,031 Abandoned
NCI E-234-2003-1-CA-04 Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas CA National Stage 2537254 Abandoned
NIAID E-142-1996-0-US-05 PRODUCTION ATTENUATED CHIMERIC RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES US CON 10/934,003 7709007 Abandoned PDF
NIDDK E-064-2004-0-HK-13 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT HK EP 04106574.7 Abandoned
NIAID E-074-2006-0-US-01 Method Of Using Adenoviral Vectors With Increased Immunity In Vivo US 60/606,273 Abandoned
NHLBI E-246-2004-0-US-01 An Improved Method To Separate And Expand Antigen-specific T Cells US 60/606,197 Abandoned
NIAID E-178-2008-1-US-01 Antigenic Conservation and immunogenicity of the HIV CO-receptor binding site US 60/606,053 Abandoned
NIDCR E-053-2002-0-SG-13 Methods and Composition for the Promotion of Hair Growth Utilizing Actin Binding Peptides SG National Stage 200403892-3 Abandoned
NCI E-256-2004-0-US-01 Methods and Compositions Related to the Inhibitors of HIV using RNase H Inhibitors US 60/605,165 Abandoned
NIDA E-024-2005-0-CA-04 Pyridomorphinans, Pyridazinomorphinans And Use Thereof CA National Stage 2538146 Abandoned
NIDA E-024-2005-0-AU-03 Pyridomorphinans, Pyridazinomorphinans And Use Thereof AU National Stage 2004267994 Abandoned
NIAID E-142-1996-3-AU-11 Production of Attenuated Respiratory Syncytial Virus Vaccines from Cloned Nucleotide Sequences AU DIV 2004205289 Abandoned
NCI E-323-2003-0-PCT-02 Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use PCT PCT PCT/US2004/28004 Expired
NIDA E-024-2005-0-EP-05 Pyridomorphinans, Pyridazinomorphinans And Use Thereof EP National Stage 04786589.4 Abandoned
NIDA E-024-2005-0-PCT-02 Pyridomorphinans, Pyridazinomorphinans And Use Thereof PCT PCT PCT/US04/027802 Expired
NIDA E-024-2005-0-JP-07 Pyridomorphinans, Pyridazinomorphinans And Use Thereof JP National Stage 2006-524861 Expired
NIAID E-270-2005-0-US-01 Method of eliciting an immune response against HIV US 60/605,187 Abandoned
NIAID E-337-2004-0-US-01 Recombinant MVA Viruses Expressing Clade A/G and Clade B Modified HIV Env, Gag, and POL Genes US 60/604,918 Abandoned
NCI E-098-2004-0-US-01 Template Methods and Devices for Preparing Sample Arrays US ORD 10/928,656 7854899 Issued PDF
NIAID E-329-2000-0-US-06 ACYLTHIOLS AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS US National Stage 10/485,165 7528274 Expired PDF
NICHD E-096-2004-0-US-01 FLOW-THROUGH, THERMAL-EXPANSION-COMPENSATED CELL FOR LIGHT SPECTROSCOPY US ORD 10/926,405 7355697 Abandoned PDF
NHLBI E-179-2004-0-PCT-02 Anti-Cancer Vaccines PCT PCT PCT/US2004/27790 Expired
NHLBI E-179-2004-0-US-03 Anti-cancer Vaccines US ORD 10/926,852 Abandoned
NHLBI E-179-2004-0-EP-07 Anti-Cancer Vaccines EP National Stage 04782297.8 Abandoned
NHLBI E-179-2004-0-AU-04 Anti-Cancer Vaccines AU National Stage 2004267506 Abandoned
NHLBI E-179-2004-0-JP-06 Anti-Cancer Vaccines JP National Stage 2006-524856 Abandoned
NHLBI E-179-2004-0-CA-05 Anti-Cancer Vaccines CA National Stage 2536654 Abandoned
NCI E-259-1998-2-US-07 Variants of Humanized Anti-Carcinoma MAB CC49 US DIV 10/927,433 7256004 Expired PDF
NCI E-233-2004-0-US-01 Live Microbial Microbicides US 60/604,051 Abandoned
NCI E-124-2001-1-US-02 Peptide Agonists of Prostate-Specific Antigen and Uses Therefor US National Stage 10/497,003 7247615 Expired PDF
NHLBI E-277-2004-0-US-01 Chromatography Apparatus and Method US 60/603,975 Abandoned
NIAID E-241-2001-0-US-07 Development of a Preventive Vaccine for Filovirus Infection in Primates US National Stage 10/491,121 7635688 Issued PDF
NINDS E-167-2004-0-US-02 Inducing Sterility In Fish By Disrupting The Development Of The GNRH System US National Stage 10/924,001 7194978 Expired PDF
NCI E-317-2004-1-US-01 Synthetic Metal Ion Chelating Amino Acid Suitable For Use In Solid Phase Peptide Synthesis US 60/603,781 Abandoned
NIA E-116-2004-0-US-01 Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutic Agents US 60/602,651 Abandoned
NCI E-075-2004-1-US-01 Transcriptional Profiling Of The NCI 60 Cell Panel By Quantitative RT-PCT Predicts Substrates And Inhibitors Of ABC Transporters And Identifies Compounds Preferentially Killing Multidrug Resistant Cells US 60/602,640 Abandoned
NCI E-044-1992-0-JP-25 DAMPENING OF AN IMMUNODOMINANT EPITOPE OF AN ANTIGEN FOR USE IN PLANT, ANIMAL AND HUMAN VACCINES AND IMMUNOTHERAPIES JP DIV 2005-367769 Abandoned
NIEHS E-034-2002-0-US-03 Mutated Constitutively Active Nuclear Orphan Receptor US National Stage 10/505,183 7365160 Abandoned PDF
NIA E-354-2004-0-US-01 Biomarkers for Osteoarthritis US 60/602,334 Abandoned
NIA E-183-2003-0-NZ-16 Method For Treating Cognitive Disorders NZ National Stage 534726 Abandoned
NCI E-010-2004-1-US-01 Modulating Kinase p38 Activity US 60/602,436 Abandoned
NCI E-011-1998-0-US-04 Mammalian Selenoprotein Differentially Expressed in Tumor Cells US DIV 10/919,554 7442543 Abandoned PDF
NHLBI E-080-2002-0-US-03 Modified Defensins And Their Use US National Stage 10/504,838 7511015 Abandoned PDF
NINDS E-056-2003-1-PCT-01 Direct Differentiation Of Embryonic Stem (ES) Cells To Neurons In Serum-free Medium In The Absence Of Embryoid Body (EB) Intermediates PCT PCT COMB PCT/US2004/026486 Abandoned